This site is intended for UK healthcare professionals only

AstraZeneca has provided sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia.

Chronic Conditions Month 2024

Cardiovascular On-demand

Practical experience in enabling RAASi optimisation in patients with heart failure

Presenter: Dr Aaron Wong, Consultant Cardiologist and General Physician, Princess of Wales Hospital, Bridgend, Wales

This is an educational, promotional video funded and created by
AstraZeneca intended for UK HCPs.

Prescribing information for Lokelma (sodium zirconium cyclosilicate) in Great Britain is available here

Prescribing information for Lokelma (sodium zirconium cyclosilicate) in Northern Ireland is available here

Adverse events should be reported.  Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033

If you have any questions, please contact [email protected]

Therapy webcast sponsor

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca operates in over 100 countries and its medicines are used by millions of patients worldwide.

With a proud 100-year heritage in advancing UK science, today AstraZeneca is the UK’s leading biopharmaceutical company. AstraZeneca is based in six different locations across the UK, with its global headquarters in Cambridge. In the UK, around 8,600 employees work in research and development, manufacturing, supply, sales and marketing. We supply around 35 different medicines to the NHS.

GB-53572 | April 2024

For healthcare professionals only

Are you a healthcare professional?

The information is intended for healthcare professionals only.
Please confirm below.